— Know what they know.
Not Investment Advice

PTCT Short Interest

PTC Therapeutics, Inc.
1W: -1.3% 1M: -5.8% 3M: -16.6% YTD: -19.1% 1Y: -6.5% 3Y: +167.5% 5Y: +71.2%
$62.09
+1.02 (+1.67%)
 
Weekly Expected Move ±5.7%
$54 $57 $61 $64 $68
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 39 · $5.2B mcap · 74M float · 1.86% daily turnover · Short 57% of daily vol
Credit Risk of going bust: lower than 68% of companies Debt: 11.8% of company value Bonds: $48.8M held by 18 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.66 (down 99%), PTC Therapeutics, Inc. would be worth roughly what it owes.
Total debt $696.5M against a stock market value of $5.18B.
Distance to default 7.32 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $323.2M (short-term plus half of long-term), stock volatility 40.6%; Altman Z'' 1.03. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Short Volume Summary

2026-10-26
46.3%
Short Ratio
of total volume
48.2%
20-Day Avg
51.9%
50-Day Avg
▲ Rising
5-Day Trend
0.1M
Short Volume
0.3M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 137,615 293,514 46.9%
NYSE 2,970 9,648 30.8%
BATS 334 1,489 22.4%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms